Concepedia

Early Experience With Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration

Ana Bety Enríquez, Caroline R. Baumal, Ashley M. Crane, André J. Witkin, David R. Lally, Michelle C. Liang, José Ramón Enríquez, David Eichenbaum

JAMA Ophthalmology · 2021 · 74 citations · 27 references

DOIFull text

Open access

Abstract

In this analysis of brolucizumab IVI for nAMD, VA remained stable, with a reduction in central subfield thickness. Intraocular inflammation events ranged from mild with spontaneous resolution to severe occlusive retinal vasculitis in 1 eye.

References

27

World Medical Association Declaration of Helsinki

JAMA · 2013 · 27.3K citations

, , +19

Proper Method for Calculating Average Visual Acuity

Jack T. Holladay · Journal of Refractive Surgery · 1997 · 1.1K citations

, , +2

Visual Acuities “Hand Motion” and “Counting Fingers” Can Be Quantified with the Freiburg Visual Acuity Test

Kilian Schulze-Bonsel, Nicolas Feltgen, H Burau et al. · Investigative Ophthalmology & Visual Science · 2006 · 928 citations

HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration

Pravin U. Dugel, Adrian Koh, Yuichiro Ogura et al. · Ophthalmology · 2019 · 871 citations · Full text

Standardizatlon of Vitreal inflammatory Activity in Intermediate and Posterior Uveitis

Robert B. Nussenblatt, Alan G. Palestine, Chi‐Chao Chan et al. · Ophthalmology · 1985 · 668 citations

, , +5